UNC79
Basic information
Region (hg38): 14:93333218-93707876
Previous symbols: [ "KIAA1409" ]
Links
Phenotypes
GenCC
Source:
- complex neurodevelopmental disorder (Strong), mode of inheritance: AD
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (77 variants)
- not provided (9 variants)
- UNC79-related condition (2 variants)
- Autism spectrum disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UNC79 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 80 | 82 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region ? | 0 | |||||
non coding ? | 0 | |||||
Total | 0 | 0 | 86 | 3 | 0 |
Variants in UNC79
This is a list of pathogenic ClinVar variants found in the UNC79 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-93347282-G-A | not specified | Uncertain significance (Oct 10, 2023) | ||
14-93347296-G-T | not specified | Uncertain significance (May 11, 2022) | ||
14-93348059-C-T | not specified | Uncertain significance (Jun 22, 2021) | ||
14-93348103-C-A | not specified | Uncertain significance (Nov 12, 2021) | ||
14-93467669-A-T | UNC79-related disorder | Likely benign (Sep 29, 2020) | ||
14-93467670-G-T | UNC79-related disorder | Likely benign (Sep 29, 2020) | ||
14-93467751-A-T | UNC79-related disorder | Uncertain significance (Feb 28, 2024) | ||
14-93474273-C-A | UNC79-related disorder | Likely benign (Jun 01, 2022) | ||
14-93477683-G-A | Inborn genetic diseases | Uncertain significance (Nov 20, 2023) | ||
14-93477694-A-C | Inborn genetic diseases | Uncertain significance (Dec 20, 2023) | ||
14-93487703-C-G | Inborn genetic diseases | Uncertain significance (Jul 09, 2021) | ||
14-93497184-C-T | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
14-93528586-C-T | Inborn genetic diseases | Uncertain significance (Aug 09, 2021) | ||
14-93528648-T-A | UNC79-related disorder | Uncertain significance (Jan 16, 2024) | ||
14-93532564-A-G | Inborn genetic diseases | Uncertain significance (Dec 22, 2023) | ||
14-93532573-A-T | Uncertain significance (Oct 13, 2023) | |||
14-93538049-C-T | Inborn genetic diseases | Uncertain significance (Jul 09, 2021) | ||
14-93538070-C-T | Inborn genetic diseases | Uncertain significance (Dec 07, 2022) | ||
14-93538125-C-T | Inborn genetic diseases | Uncertain significance (Jan 04, 2024) | ||
14-93540676-G-C | UNC79-related disorder | Likely benign (Dec 13, 2022) | ||
14-93540715-C-T | Inborn genetic diseases | Uncertain significance (Jan 24, 2024) | ||
14-93542500-C-T | Inborn genetic diseases | Uncertain significance (Dec 16, 2022) | ||
14-93542524-C-T | Uncertain significance (Feb 14, 2023) | |||
14-93542529-G-A | Inborn genetic diseases | Uncertain significance (Jun 05, 2023) | ||
14-93542578-G-C | Inborn genetic diseases | Uncertain significance (Sep 28, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UNC79 | protein_coding | protein_coding | ENST00000256339 | 47 | 374658 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 1.00e-12 | 125725 | 0 | 22 | 125747 | 0.0000875 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 4.16 | 934 | 1.37e+3 | 0.683 | 0.0000760 | 16253 |
Missense in Polyphen | 409 | 727.09 | 0.56252 | 8881 | ||
Synonymous | 1.05 | 510 | 541 | 0.943 | 0.0000344 | 4712 |
Loss of Function | 9.40 | 11 | 124 | 0.0888 | 0.00000663 | 1436 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000424 | 0.000424 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.000231 | 0.000231 |
European (Non-Finnish) | 0.0000618 | 0.0000615 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the NALCN sodium channel complex, a cation channel activated either by neuropeptides substance P or neurotensin that controls neuronal excitability. {ECO:0000250}.;
- Pathway
- Stimuli-sensing channels;Ion channel transport;Transport of small molecules
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- rvis_EVS
- -1.11
- rvis_percentile_EVS
- 6.63
Haploinsufficiency Scores
- pHI
- 0.137
- hipred
- Y
- hipred_score
- 0.733
- ghis
- 0.568
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Unc79
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- ion transmembrane transport;multicellular organism growth;behavioral response to ethanol
- Cellular component
- plasma membrane;integral component of membrane
- Molecular function